Parkinson's Disease clinical trials in Washington
22 active Parkinson's Disease trials with a site in Washington. Describe your situation to see which ones look like a fit.
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- A Study of Buntanetap in Participants With PD
- Use of CereGate Therapy for Freezing of Gait in PD
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Parkinson's Foundation PD GENEration Genetic Registry
- The GBA Multimodal Study in Parkinson's Disease
- Registry of Deep Brain Stimulation With the VERCISEā¢ System: Vercise DBS Registry
- The Parkinson's Genetic Research Study
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Modifiable Variables in Parkinsonism (MVP)
- Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
- Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
- Pacific Northwest Udall Center (PANUC) Clinical Core
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.